☰

Nicolas J. Schlienz, Ph.D. - Publications

Affiliations: 
2015- Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine, Baltimore, MD, United States 
Area:
Cannabis, Tobacco, Withdrawal, Reward Processing, Cognition
Tree Info Grants Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Lee DC, Schlienz NJ, Herrman ES, Martin EL, Leoutsakos J, Budney AJ, Smith MT, Tompkins DA, Hampson AJ, Vandrey R. Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder. Journal of Substance Use and Addiction Treatment. 209180. PMID 37802317 DOI: 10.1016/j.josat.2023.209180  0.764
2022 Garcia-Romeu A, Elmore J, Mayhugh RE, Schlienz NJ, Martin EL, Strickland JC, Bonn-Miller M, Jackson H, Vandrey R. Online survey of medicinal cannabis users: Qualitative analysis of patient-level data. Frontiers in Pharmacology. 13: 965535. PMID 36147312 DOI: 10.3389/fphar.2022.965535  0.583
2021 Martin EL, Strickland JC, Schlienz NJ, Munson J, Jackson H, Bonn-Miller MO, Vandrey R. Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial. Frontiers in Psychiatry. 12: 729800. PMID 34566726 DOI: 10.3389/fpsyt.2021.729800  0.554
2021 Strickland JC, Jackson H, Schlienz NJ, Salpekar JA, Martin EL, Munson J, Bonn-Miller MO, Vandrey R. Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy. Epilepsy & Behavior : E&B. 122: 108205. PMID 34311183 DOI: 10.1016/j.yebeh.2021.108205  0.545
2021 Mahoney MC, Park E, Schlienz NJ, Duerr C, Hawk LW. Transitioning to remote clinic visits in a smoking cessation trial during the SARS coronavirus-2 pandemic: Mixed methods evaluation. Jmir Formative Research. PMID 33878020 DOI: 10.2196/25541  0.601
2020 Schlienz NJ, Scalsky R, Martin EL, Jackson H, Munson J, Strickland JC, Bonn-Miller MO, Loflin M, Vandrey R. A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health. Cannabis and Cannabinoid Research. PMID 33998852 DOI: 10.1089/can.2019.0096  0.558
2020 Mahoney MC, Ashare R, Schlienz N, Duerr C, Hawk LW. Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform. Journal of Substance Abuse Treatment. 117: 108100. PMID 32811627 DOI: 10.1016/J.Jsat.2020.108100  0.748
2020 Schlienz NJ, Spindle TR, Cone EJ, Herrmann ES, Bigelow GE, Mitchell JM, Flegel R, LoDico C, Vandrey R. Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug and Alcohol Dependence. 211: 107969. PMID 32298998 DOI: 10.1016/J.Drugalcdep.2020.107969  0.622
2019 Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, Hayes E, Vandrey R. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users. Journal of Analytical Toxicology. PMID 31095692 DOI: 10.1093/Jat/Bkz038  0.632
2019 Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, Hayes E, Vandrey R. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid. Journal of Analytical Toxicology. PMID 30615181 DOI: 10.1093/Jat/Bky104  0.618
2018 Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, Hayes E, Vandrey R. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial. Jama Network Open. 1: e184841. PMID 30646391 DOI: 10.1001/jamanetworkopen.2018.4841  0.591
2018 Lee DC, Schlienz NJ, Peters EN, Dworkin RH, Turk DC, Strain EC, Vandrey R. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug and Alcohol Dependence. 194: 500-517. PMID 30530238 DOI: 10.1016/J.Drugalcdep.2018.10.020  0.742
2018 Schlienz NJ, Huhn AS, Speed TJ, Sweeney MM, Antoine DG. Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment. International Review of Psychiatry (Abingdon, England). 1-8. PMID 30398080 DOI: 10.1080/09540261.2018.1509843  0.69
2018 Weigard A, Huang-Pollock C, Heathcote A, Hawk L, Schlienz NJ. A cognitive model-based approach to testing mechanistic explanations for neuropsychological decrements during tobacco abstinence. Psychopharmacology. PMID 30182252 DOI: 10.1007/S00213-018-5008-3  0.617
2018 Schlienz NJ, Lee DC. Co-use of cannabis, tobacco, and alcohol during adolescence: policy and regulatory implications. International Review of Psychiatry (Abingdon, England). 1-12. PMID 29944032 DOI: 10.1080/09540261.2018.1465399  0.68
2018 Schlienz NJ, Lee DC, Stitzer ML, Vandrey R. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Drug and Alcohol Dependence. 187: 254-260. PMID 29689485 DOI: 10.1016/J.Drugalcdep.2018.02.022  0.762
2018 Barrett FS, Schlienz NJ, Lembeck N, Waqas M, Vandrey R. "Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs. Cannabis and Cannabinoid Research. 3: 85-93. PMID 29682608 DOI: 10.1089/can.2017.0052  0.526
2018 Houston RJ, Schlienz NJ. Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 30-40. PMID 29397076 DOI: 10.1016/J.Bpsc.2017.09.006  0.636
2018 Martin EL, Schlienz NJ, Herrmann ES, Budney AJ, Lee DC, Hampson A, Smith M, Leoutsakos JS, Stitzer ML, Vandrey RG. 1000 Targeting Sleep in Adults Seeking Treatment for Cannabis Use Disorder Sleep. 41: A370-A370. DOI: 10.1093/Sleep/Zsy061.999  0.746
2018 Vandrey R, Budney A, Herrmann E, Schlienz N, Hampson A, Smith M, Stitzer M. 166. Targeting Sleep Disturbance in the Treatment of Cannabis Use Disorders Biological Psychiatry. 83: S67. DOI: 10.1016/J.Biopsych.2018.02.184  0.726
2017 Schlienz NJ, Cone EJ, Herrmann ES, Lembeck NA, Mitchell JM, Bigelow GE, Flegel R, LoDico CP, Hayes ED, Vandrey R. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults. Journal of Analytical Toxicology. PMID 29300962 DOI: 10.1093/Jat/Bkx102  0.582
2017 Schlienz NJ, Budney AJ, Lee DC, Vandrey R. Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences. Current Addiction Reports. 4: 75-81. PMID 29057200 DOI: 10.1007/S40429-017-0143-1  0.741
2017 Schlienz NJ, Hawk LW. Probing the Behavioral and Neurophysiological Effects of Acute Smoking Abstinence on Drug and Nondrug Reinforcement During a Cognitive Task. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 19: 729-737. PMID 28486713 DOI: 10.1093/Ntr/Ntw277  0.628
2017 Schlienz N, Hawk L. A behavioral and neurophysiological examination of the impact of smoking abstinence on drug and non-drug reinforcement Drug and Alcohol Dependence. 171: e185. DOI: 10.1016/J.Drugalcdep.2016.08.507  0.593
2016 Motschman CA, Gass JC, Wray JM, Germeroth LJ, Schlienz NJ, Munoz DA, Moore FE, Rhodes JD, Hawk LW, Tiffany ST. Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline. Drug and Alcohol Dependence. 169: 180-189. PMID 27863344 DOI: 10.1016/J.Drugalcdep.2016.10.018  0.734
2015 Schlauch RC, Crane CA, Houston RJ, Molnar DS, Schlienz NJ, Lang AR. Psychometric Evaluation of the Substance Use Risk Profile Scale (SURPS) in an Inpatient Sample of Substance Users Using Cue-Reactivity Methodology. Journal of Psychopathology and Behavioral Assessment. 37: 231-246. PMID 26052180 DOI: 10.1007/S10862-014-9462-X  0.738
2014 Schlienz NJ, Hawk LW, Tiffany ST, O'Connor RJ, Mahoney MC. The impact of pre-cessation varenicline on behavioral economic indices of smoking reinforcement. Addictive Behaviors. 39: 1484-90. PMID 24949949 DOI: 10.1016/J.Addbeh.2014.05.008  0.626
2013 Schlienz NJ, Hawk LW, Rosch KS. The effects of acute abstinence from smoking and performance-based rewards on performance monitoring. Psychopharmacology. 229: 701-11. PMID 23681159 DOI: 10.1007/S00213-013-3131-8  0.644
2012 Rhodes JD, Hawk LW, Ashare RL, Schlienz NJ, Mahoney MC. The effects of varenicline on attention and inhibitory control among treatment-seeking smokers. Psychopharmacology. 223: 131-8. PMID 22526531 DOI: 10.1007/S00213-012-2700-6  0.779
2012 Hawk LW, Ashare RL, Lohnes SF, Schlienz NJ, Rhodes JD, Tiffany ST, Gass JC, Cummings KM, Mahoney MC. The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial. Clinical Pharmacology and Therapeutics. 91: 172-80. PMID 22130118 DOI: 10.1038/Clpt.2011.317  0.731
2010 Godleski SA, Ostrov JM, Houston RJ, Schlienz NJ. Hostile attribution biases for relationally provocative situations and event-related potentials. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 76: 25-33. PMID 20117151 DOI: 10.1016/J.Ijpsycho.2010.01.010  0.576
Show low-probability matches.